4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-418101
General Counsel and Secretary sold 1,990 shares at $60.04 ($119,481)
- General Counsel and Secretary acquired 1,990 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,990 | $13.62 | $27,104 | 96,774 | D |
| 2026-10-06 | Sale : show line 2 in the form 10b5-1 | −1,990 | $60.04 | $119,481 | 94,784 | D |
| Open-market sales · 1,990 sh · avg $60.04 · $119,481 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-06 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −1,990 | 81,242 | D |
Loading xslF345X06/ownership.xml…